• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Newronika raises €8m Series A for closed-loop DBS

Newronika raises €8m Series A for closed-loop DBS

September 27, 2019 By Sean Whooley

Newronika said yesterday that it raised more than $9 million in Series A funding for its closed-loop deep brain stimulation system.

The funding totals nearly $9.2 million (€8.4 million) for the spin-off from Milan’s Policlinico and University of Milan research centers. French venture capital fund Omnes led the round, joined by existing investors Innogest Capital and Indaco Venture Partners SGR. F3F and an undisclosed family office also participated, according to a news release.

Newronika’s closed-loop DBS system is designed to restore brain and body function by translating the company’s knowledge of bio-signal decoding into clinical practice. The company said its technology will be initially applied to Parkinson’s disease patients, with other indications slated to be pursued down the road.

The proceeds are earmarked for a first-in-human clinical study ahead of a bid for CE Mark approval and an investigative device exemption from the FDA.

“Newronika is the first company to develop a closed-loop system for the treatment of Parkinson’s disease. Newronika’s technology is at the forefront of deep brain stimulation,” CEO Lorenzo Rossi said in prepared remarks. “Our solution is most needed and awaited by the medical community since the invention of the first DBS system by Medtronic (NYSE:MDT), more than 20 years ago. Our technology can record the electrical activity of the deep brain nuclei and adapt the stimulation in real-time. This is a game-changer for the neurological field, opening many potential applications. We want to build a platform of indications where our technology could be used, from Parkinson’s disease to traumatic brain injury and beyond.”

“This round puts Newronika straight into the global competition for DBS technology and turns our company into a player to be reckoned with,” added CFO Alain Garcinuño. “We are delighted to have secured the necessary funding to reach a clear value inflection point in the coming months.”

Filed Under: Featured, Funding Roundup, Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: Newronika

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy